No. of Recommendations: 2
Coloplast must feel like the nerd at the school dance. On this board, its got no rizz compared to UK food companies. But for those who might like a more health tech oriented play in the non-US space, CLPBY is down below $9. I think that is a reasonable price. If it goes down from here, it will be because of valuation multiple contraction (entirely possible because they are still pretty high) rather than because of business fundamentals. I think the stock is capable of rerating with a new CEO and what I hope / expect will be a normalized growth year for the business with improving profitability. Their underlying markets are fine and good long term bets. They are a pretty good operator in their businesses with ongoing opportunities to expand their addressable market.
I have already bought a full allocation, but if it did drop to something like <$8.50, I would probably add. One thing is that while its a $20B market cap stock and has analyst coverage, it is definitely not a media stock and trades with little news flow in the US. I suspect trading volume is also very limited. So best to think of this as a stock you would buy to hold for a long time.
